Ignite Creation Date:
2024-05-06 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05037669
Status:
WITHDRAWN
Last Update Posted:
2023-06-22
First Post:
2021-08-24
Brief Title:
Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor PACE CART19 in Patients With Relapsed Or Refractory CD19 Leukemia and Lymphoma
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Lymphoblastic Leukemia |
| Chronic Lymphocytic Leukemia |
| Non Hodgkin Lymphoma |
Keywords: